2017
2
$82,500
$100,000
$843,000
No
Explore the Alleviant Health Centers franchise opportunity in the USA—a pioneering outpatient model offering ketamine infusion therapy, transcranial magnetic stimulation (TMS), and related holistic mental health services. Backed by a growing reputation in modern therapeutic solutions, Alleviant positions itself as a forward-looking, clinically supported, and rapidly scalable franchise brand. With rising demand for alternative mental health treatments across the U.S., this franchise stands out in credibility, innovation, and profitability potential.
Specialized Advanced Therapies: Providing FDA-compliant ketamine infusions and TMS, offering alternatives to conventional psychiatric treatments.
Clinically Recognized Approach: Emphasizes safe, evidence-based therapies to address depression, chronic pain, and treatment-resistant conditions.
Brand Differentiation: Widely differentiated from generic clinics by its neuroscience-backed protocols, modern tech, and therapeutic focus.
Rising mental health awareness and destigmatization are fueling demand for non-traditional modalities.
Increasing insurance coverage and expanding credentialing for ketamine and TMS procedures enhance accessibility.
Telehealth and outpatient models are becoming mainstream preferences, maximizing convenience while controlling costs.
With only three U.S. locations (two franchised, one corporate), Alleviant offers significant room for franchise-driven expansion
As mental health continues to be a priority, brand visibility and client trust are expected to rise.
Moderate-to-high initial capital budgets indicate serious therapeutic capabilities and solid infrastructure.
Franchisees benefit from a proven operational framework and increasing ROI as the network scales.
Site selection guidance tailored to demographic and regulatory landscapes.
Design and build-out assistance to meet medical and patient-centered standards.
Help with staffing requirements, licensing, and credentialing processes.
Standard operating procedures for patient intake, treatment protocols, and safety compliance.
Access to proprietary treatment frameworks leveraging best practices in ketamine/TMS therapy.
Brand-aligned templates for digital marketing: website, SEO, social media, and patient-focused content.
Academic materials for practitioner and staff training, alongside patient educational resources.
Access to continuing education and clinical training updates.
Regular quality assurance, compliance audits, and outcome tracking.
Centralized supply procurement and bulk pricing arrangements (TMS units, infusion meds).
Peer network collaboration and regional group support sessions.
Background & Attributes
Entrepreneurs with a strong interest or background in healthcare, mental health services, or wellness management.
Licensees or clinical professionals: psychologists, psychiatrists, nurse practitioners, physicians, or allied health leaders interested in an outpatient behavioral health venture.
Capable of meeting financial requirements; committed to patient-first care and innovation in mental health.
Passion & Vision
A deep commitment to reducing mental health stigma and offering evidence-based alternative therapies.
Strong interpersonal skills and community engagement mindset.
Investment & Location Preference
Located in metropolitan areas or suburban U.S. markets with underserved mental health needs.
Prefer zones with favorable reimbursement patterns and regulatory clarity for ketamine/TMS services.
| Financial Element | Amount / Details |
|---|---|
| Total Investment Range | $253,000 – $843,000 (includes build-out, equipment, licenses, working capital) |
| Minimum Cash Required | $82,500 |
| Franchise Fee | $100,000 (one-time upfront fee) |
| Royalty Fee | 20% of gross revenue (ongoing) |
| Marketing/Brand Fee | Not publicly disclosed (varies, confirm with FDD) |
| Infrastructure / Build-Out Costs | Includes clinic setup, TMS devices, infusion equipment, IT systems, furniture, leasehold improvements |
| Marketing Budget (Initial Launch) | To be confirmed – typically local advertising & digital campaigns in partnership with franchisor |
| Working Capital | Recommended reserve for 3–6 months of operations |
| Expected ROI (Payback Period) | Approx. 8.8 years (midpoint estimate) |
| Break-Even Time | Varies by location, patient flow & insurance approvals |
| Potential Revenue Streams | Ketamine infusion therapy, TMS sessions, psychiatric consultations, outpatient therapies, wellness services |
